BioPharmCatalyst

biopharmcatalyst.bsky.social

12 March 2025 18:33

$ARVN Phase 3 VERITAC-2 trial showed that Vepdegestrant monotherapy significantly improves progression-free survival in ER+/HER2 breast cancer patients with ESR1 mutations, but not in the overall patient population. See More Biotech Updates👇 www.biopharmcatalyst.com/news/2025/2s...

Rich Law

drrichjlaw.bsky.social

12 March 2025 18:33

Roche signs biggest-ever obesity drug deal with Danish Zealand Pharma; $5.3bn licensing agreement for next-generation treatment. www.ft.com/content/80c5...

Rich Law

drrichjlaw.bsky.social

12 March 2025 10:50

Zealand Pharma ( $ZEAL.CO) partners with Roche on its amylin analog in a deal worth up to $5.3B, plus 50% upside on profits, with $1.65Bn upfront! 👏 endpts.com/zealand-part...

BioPharmCatalyst

biopharmcatalyst.bsky.social

11 March 2025 17:52

$TSVT announced a merger agreement with $BMY to be acquired for $5.00 per share in an all-cash deal valued at $286 million, representing an 88% premium to its March 7, 2025 closing price. See More Pre-market Movers 👇 www.biopharmcatalyst.com/news/2025/2s... $ARVN $CUTR $SNOA $TNON $BVS $MYO $HCSC

BioPharmCatalyst

biopharmcatalyst.bsky.social

08 March 2025 14:16

$BTAI announced that it has achieved 33% enrollment in its 200-patient SERENITY At-Home trial, a pivotal Phase 3 study assessing the safety of BXCL501. See More Biotech Updates👇 www.biopharmcatalyst.com/news/2025/bi...